Jacques Schrenzel

Active 1998–2025

165
Papers
18,025
Citations
84
h-index
154
i10-index

Citations

Citations per year for Jacques Schrenzel1981: 1 citations1992: 1 citations1997: 3 citations1998: 1 citations1999: 4 citations2000: 6 citations2001: 17 citations2002: 9 citations2003: 17 citations2004: 24 citations2005: 39 citations2006: 88 citations2007: 61 citations2008: 88 citations2009: 152 citations2010: 156 citations2011: 239 citations2012: 276 citations2013: 275 citations2014: 255 citations2015: 231 citations2016: 283 citations2017: 218 citations2018: 199 citations2019: 679 citations2020: 657 citations2021: 598 citations2022: 557 citations2023: 357 citations2024: 559 citations2025: 240 citations2026: 7 citations1982–1991: no citations, so these years are not shown1993–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,765 citing papers, 19.9% of this breakdownChina: 892 citing papers, 10.1% of this breakdownUnited Kingdom: 540 citing papers, 6.1% of this breakdownGermany: 531 citing papers, 6% of this breakdownFrance: 498 citing papers, 5.6% of this breakdownSwitzerland: 434 citing papers, 4.9% of this breakdownItaly: 308 citing papers, 3.5% of this breakdownCanada: 269 citing papers, 3% of this breakdownNetherlands: 259 citing papers, 2.9% of this breakdownSpain: 252 citing papers, 2.9% of this breakdownAustralia: 247 citing papers, 2.8% of this breakdownBelgium: 236 citing papers, 2.7% of this breakdown
0%19.9%Other 29.6%

Fields

  • Biochemistry, Genetics and Molecular Biology42.6%
  • Medicine36.8%
  • Immunology and Microbiology5.2%
  • Dentistry3.6%
  • Agricultural and Biological Sciences3.2%
  • Environmental Science2.3%
  • Other6.3%

Topics

  • Gut microbiota and health8.5%
  • Antimicrobial Resistance in Staphylococcus6%
  • Bacterial biofilms and quorum sensing4.1%
  • Bacterial Identification and Susceptibility Testing3.9%
  • Antibiotic Resistance in Bacteria3.9%
  • Diet and metabolism studies3%
  • Other70.6%

Coauthors

All papers

Open in search
  1. Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice

    Authors: , , , , , , , , , , , , - Diabetes 2011 cited by 1,060

  2. Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications

    Authors: , , , , , , , - FEMS Immunology & Medical Microbiology 2011 cited by 499

  3. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

    Authors: , , , , , , , , , - The ISME Journal 2014 cited by 605

  4. The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet

    Authors: , , , , , , , , , , - Translational research 2020 cited by 123

  5. Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements

    Authors: , , , , , , , , , , , , , , - Cell Metabolism 2018 cited by 247

  6. Oral Dysbiosis and Inflammation in Parkinson’s Disease

    Authors: , , , , , , , , , , , , - Journal of Parkinson s Disease 2021 cited by 91

  7. Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis

    Authors: , , , , , , , , , , - Cell Reports 2019 cited by 101

  8. Root Microbiota in Primary and Secondary Apical Periodontitis

    Authors: , , , , , , , - Frontiers in Microbiology 2018 cited by 148

  9. Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care

    Authors: , , , , , , , , , , , - Critical Care 2021 cited by 112

  10. Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue

    Authors: , , , , , , , , , , , , , - Frontiers in Microbiology 2011 cited by 325

  11. The Stringent Response of Staphylococcus aureus and Its Impact on Survival after Phagocytosis through the Induction of Intracellular PSMs Expression

    Authors: , , , , , , , , - PLoS Pathogens 2012 cited by 240

  12. Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Nolte, Michael Oberle, Michael Pedersen, Valentin Pflüger, Sigrid Pranghofer, Julia Reichl, Rob J. Rentenaar, Arnaud Riat, Belén Rodríguez‐Sánchez, Camille Schilt, Ann-Kathrin Schlotterbeck, Jacques Schrenzel, Shani Troib, Elise Willems, Mandy Wootton, Dominik Ziegler, Adrian Egli - Clinical Microbiology and Infection 2022 cited by 27

  13. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection

    Authors: , , , , , , , , , , , , - Blood 2010 cited by 338

  14. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study

    Authors: , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2019 cited by 62

  15. Biology and Regulation of Staphylococcal Biofilm

    Authors: , , - International Journal of Molecular Sciences 2023 cited by 52

  16. Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections*

    Authors: , , , , , , , , , , , , , , - Critical Care Medicine 2015 cited by 193

  17. CodY in Staphylococcus aureus : a Regulatory Link between Metabolism and Virulence Gene Expression

    Authors: , , , , , , , , - Journal of Bacteriology 2009 cited by 217

  18. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota

    Authors: , , , , , , , , - Clinical Microbiology and Infection 2014 cited by 138

  19. The central and biodynamic role of gut microbiota in critically ill patients

    Authors: , , , , , , , - Critical Care 2022 cited by 102

  20. Oral and intestinal dysbiosis in Parkinson's disease

    Authors: , , , , , , , , - Revue Neurologique 2023 cited by 34

  21. The Swiss Pathogen Surveillance Platform – towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Microbial Genomics 2023 cited by 24

  22. Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding

    Authors: , , , , , , , , - Antimicrobial Agents and Chemotherapy 2007 cited by 324

  23. A Randomized Clinical Trial to Compare Fleroxacin-Rifampicin with Flucloxacillin or Vancomycin for the Treatment of Staphylococcal Infection

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2004 cited by 130

  24. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study

    Authors: , , , , , , , , , - Digestive Diseases and Sciences 2016 cited by 77